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A B S T R A C T   
The prevalence of obesity is increasing rapidly globally and has recently reached pandemic proportions. It is a 
multifactorial disorder linked to a number of non-communicable diseases such as type-2 diabetes, cardiovascular 
disease, and cancer. Over-nutrition and a sedentary lifestyle are considered the most significant causes of obesity; 
a healthy lifestyle and behavioural interventions are the most powerful ways to achieve successful weight loss, 
but to maintain this in the long term can prove difficult for many individuals, without medical intervention. 
Various pharmacological anti-obesogenic drugs have been tested and marketed in the past and have been 
moderately successful in the management of obesity, but their adverse effects on human health often outweigh 
the benefits. Natural products from plants, either in the form of crude extracts or purified phytochemicals, have 
been shown to have anti-obesogenic properties and are generally considered as nontoxic and cost-effective 
compared to synthetic alternatives. These plant products combat obesity by targeting the various pathways 
and/or regulatory functions intricately linked to obesity. Their mechanisms of action include inhibition of 
pancreatic lipase activities, an increase in energy expenditure, appetite regulation, lipolytic effects, and inhi-
bition of white adipose tissue development. In this review, we discuss the distinct anti-obesogenic properties of 
recently reported plant extracts and specific bioactive compounds, along with their molecular mechanisms of 
action. This review will provide a common platform for understanding the different causes of obesity and the 
possible approaches to using plant products in tackling this worldwide health issue.   
1. Introduction 
Obesity can be defined as a body mass index (BMI; weight in kg/ 
square of the body height in metres) of over 30 kg/m2 (Kha-
lilpourfarshbafi et al., 2018). Obesity is an international issue and a risk 
factor for other diseases including cardiovascular diseases, cancer, 
type-2 diabetes, asthma, atherosclerosis, and non-alcoholic fatty liver 
disease (NAFLD) (Corrêa and Rogero, 2019; Peters et al., 2018; 
Unamuno et al., 2018). Obesity and being overweight are the fifth 
leading causes of death globally (Chandrasekaran et al., 2012). Ac-
cording to one estimation, approximately 921 million people were obese 
or overweight throughout the world in 1980 and by 2013 this number 
had increased to 2.1 billion (Castillo et al., 2019; Ng et al., 2014) – 
increasing from approximately 20%–30% of the global population. It is 
now widely acknowledged that the imbalance between the intake and 
expenditure of energy results in obesity (Ahmad et al., 2020; Parray 
et al., 2018). 
Sedentary lifestyles and other environmental risk factors are 
considered major causes of obesity (Fig. 1) but they are not entirely 
responsible: genetic mutations can also lead to the condition (Choquet 
and Meyre, 2011). Mutations in genes such as Leptin (LEP), leptin re-
ceptor (LEPR), prohormone convertase 1 (PCSK1), melanocortin re-
ceptor (MC4R), proopiomelanocortin (POMC), single-minded homolog 
1 (SIM), and brain-derived neurotrophic factor (BDNF) have been re-
ported to be associated with obesity (Choquet and Meyre, 2011; Farooqi 
and O’rahilly, 2008). 
There are a number of options for the treatment of obesity. These 
focus on changes in lifestyle, such as control of diet, physical exercise, 
weight-loss medications, and weight-loss surgeries (Chandrasekaran 
et al., 2012; Sun et al., 2016). Physiological interventions such as ex-
ercise and dieting are the preferred ways to reverse weight gain, but due 
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